Search global stocks & ETFs...Ctrl K
Learn Mode
VEEV logo

VEEV - Veeva Systems Inc

318


$158.86

$2.61 (1.670%)
At market close

$158.87

$0.005 (0.003%)
After Hours 5/15/26, 11:58 PM
Stock Unlock LogoScore

4.13/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
VEEV
Valuation Score
View as %

Stock Unlock Logo
Stock Unlock
$150$309MayJulSepNovJanMar

1D
1W
1M
YTD
1Y
3Y
5Y
Max

Stock Profile
  • Market Cap
    $25.93B
  • Industry
    Health Care
  • EPS (TTM)
    $5.53
  • P/E (TTM)
    28.52
  • Div & Yield
    --
  • FCF Payout Ratio
    --
  • P/S (TTM)
    8.11
  • P/B
    3.59
  • Diluted Shares
    164.12M
  • Ex-Dividend
    --
  • Next Earnings
    06-03
  • Forward P/E
    17.63
  • Payout Ratio
    --
  • P/FCF (TTM)
    18.70
  • FCF Yield
    5.35%
  • Earnings Yield
    3.51%
  • 52 Week Range
4.13
Good
Veeva Systems Inc has grown revenue at 16.34% over the past year, which is strong growth. Also, it has more cash than liabilities meaning it could use its current cash position to be completely debt-free, if it wanted to.
Valuation Model
Key Score
4.00
Good
Management
5.00
Very Good

Growth
1.00
Very Bad

Profitability
1.00
Very Bad
Fin. Health
2.00
Bad

Dividends
--
--

Analyst
5.00
Very Good
Insider Transactions
Explore Insider Tab
Buy
Sell
20192020202120222023202420252026$0$150M$300M$450M$600M
Market News
Page 1 of 21
Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-04 16:07:26


Form ARS
Unknown Form Type

Filed on 2026-05-04 12:56:23


Form DEFA14A
Additional definitive proxy soliciting materials

Filed on 2026-05-04 12:55:29


Form DEF 14A
Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-05-04 12:54:04


Form 8-K
Current report pursuant to Section 13 or 15(d)

Filed on 2026-04-20 16:18:41


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-14 16:41:15


Form 144
Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-10 16:33:58


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 16:26:27


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 16:25:06


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 16:23:39


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 16:22:09


Form 4
Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-04-09 16:21:17

Page 1 of 21
Revenue
Earnings
Free Cash Flow
2023202420252026$0$800M$1.60B$2.40B$3.20B
Price Targets
Go to Analyst Tab
These are one year price targets for: 2027-04-25
High:
$367.50
131.3%
Avg:
$273.73
72.3%
Low:
$177.76
11.9%
(% change is relative to the current stock price: $158.86)
Analyst Recommendations
Go to Analyst Tab
3.97
Good
26%
Strong Buy (10)
47%
Buy (18)
24%
Hold (9)
3%
Sell (1)
0%
Strong Sell (0)
About
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. The company is headquartered in Pleasanton, California and currently employs 7,928 full-time employees. The company went IPO on 2013-10-16. The company offers span cloud software, data and business consulting and is designed to meet the needs of its customers and strategic business functions from research and development (R&D) through commercialization. Its product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes and partners across content management, training, quality management, assurance and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. The company owns Ostro, a brand engagement platform for life sciences that gives an artificial intelligence (AI)-driven chat experience.
  • IPO Date
    2013-10-16
  • Industry
    Health Care
  • Total Employees
    7,928
  • Exchange
    New York Stock Exchange, Inc.
  • Reporting Currency
    USD
  • GICS
    Health Care Technology
  • GICS Sub
    Health Care Technology
  • GICS Sector
    Health Care
  • GICS Group
    Health Care Equipment & Services